[{"Date":"May. 17, 2023 at 12:38 p.m. ET","Headline":"Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider","Summary":""},{"Date":"May. 19, 2023 at 7:24 p.m. ET","Headline":"Berkshire Stock Buys Still Get a Buffett Bounce\u2014but Maybe Not the Expected Results","Summary":""},{"Date":"May. 16, 2023 at 12:29 p.m. ET","Headline":"Beware of Warren Buffett\u2019s Stock Buys. They Usually Fall Flat.","Summary":""},{"Date":"May. 22, 2023 at 12:55 p.m. ET","Headline":"NASH Drugs Suffer Another Blow, but Hope Remains","Summary":""},{"Date":"May. 16, 2023 at 9:24 a.m. ET","Headline":"TikTok\u2019s Algorithm Can Be a Huge Boost for Authors. A Ban Could Hurt Book Sales.","Summary":""},{"Date":"May. 30, 2023 at 7:43 a.m. ET","Headline":"Bristol_Myers says FDA has accepted its non-small lung cancer treatment repotrectinib for priority review","Summary":""},{"Date":"Jun. 4, 2023 at 1:59 p.m. ET","Headline":"\u2018Millions of women suffering in silence\u2019: Female workers want menopause benefits, so why are they so rare?","Summary":""},{"Date":"Jun. 16, 2023 at 5:02 p.m. ET","Headline":"Bristol Myers Squibb sues federal government over Medicare drug negotiations: report","Summary":""},{"Date":"Jun. 17, 2023 at 10:38 a.m. ET","Headline":"Experts say the stock market is in a bull market. What bull market?","Summary":""},{"Date":"Jun. 17, 2023 at 8:20 a.m. ET","Headline":"Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.","Summary":""},{"Date":"Jun. 25, 2023 at 4:00 a.m. ET","Headline":"The Market Rally Made Stocks Expensive. These Are Still Cheap.","Summary":""},{"Date":"Jul. 6, 2023 at 10:53 a.m. ET","Headline":"4 Big Pharma Stocks On Sale Right Now","Summary":""},{"Date":"Jul. 13, 2023 at 11:50 a.m. ET","Headline":"Big Pharma Ramps Up Fight Against Medicare Price Negotiations","Summary":""},{"Date":"Jul. 15, 2023 at 8:52 a.m. ET","Headline":"Worried that stocks are too expensive? This value approach can highlight bargains.","Summary":""},{"Date":"Jul. 18, 2023 at 4:40 p.m. ET","Headline":"Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program","Summary":""},{"Date":"Jul. 20, 2023 at 1:53 p.m. ET","Headline":"Johnson & Johnson Stock Jumps on Earnings Beat. But Talc Worries Loom.","Summary":""},{"Date":"Jul. 18, 2023 at 5:36 p.m. ET","Headline":"The Fight Against Alzheimer\u2019s Goes Beyond Plaque. Tangles Are a Target, Too.","Summary":""},{"Date":"Jul. 21, 2023 at 8:03 p.m. ET","Headline":"Lilly Joins Biogen as Alzheimer\u2019s Drugs Finally Emerge","Summary":""},{"Date":"Jul. 21, 2023 at 7:23 a.m. ET","Headline":"Bristol Myers Gets CHMP Backing for Opdivo in Expanded Melanoma Use >BMY","Summary":""},{"Date":"Jul. 24, 2023 at 7:56 a.m. ET","Headline":"Immatics shares jump after investment from Bristol Myers Squibb","Summary":""},{"Date":"Jul. 23, 2023 at 3:00 p.m. ET","Headline":"Microsoft, GM, Verizon, Alphabet, Exxon Mobil, Meta, and More Stocks to Watch This Week","Summary":""},{"Date":"Jul. 27, 2023 at 12:24 p.m. ET","Headline":"Bristol Myers Slashes Forecast on Tumbling Revlimid Sales","Summary":""},{"Date":"Jul. 27, 2023 at 7:17 a.m. ET","Headline":"Bristol Myers stock takes a hit from earnings miss and lower outlook amid disappointing Revlimid sales","Summary":""},{"Date":"Jul. 29, 2023 at 10:34 a.m. ET","Headline":"These 7 momentum stocks ignited the market. Look out when they start to fall.","Summary":""},{"Date":"Jul. 31, 2023 at 12:30 p.m. ET","Headline":"Drugmakers Want to Crush Medicare\u2019s Pricing Power. They\u2019ll Probably Succeed.","Summary":""},{"Date":"Aug. 10, 2023 at 7:23 a.m. ET","Headline":"Bristol Myers Sets $4 Billion Accelerated Stock Buyback >BMY","Summary":""},{"Date":"Aug. 10, 2023 at 7:08 a.m. ET","Headline":"Bristol Myers Squibb stock extends bounce after announced $4 billion accelerated buyback agreements","Summary":""},{"Date":"Aug. 16, 2023 at 12:30 a.m. ET","Headline":"6 Pharma and Life Sciences Stocks That Are Actually Up This Year","Summary":""},{"Date":"Aug. 22, 2023 at 4:38 p.m. ET","Headline":"BMY Gets European Approval for Opdivo as Treatment for Some Melanoma Patients","Summary":""},{"Date":"Aug. 26, 2023 at 1:07 p.m. ET","Headline":"As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list","Summary":""},{"Date":"Aug. 29, 2023 at 3:26 p.m. ET","Headline":"Eli Lilly and Other Pharma Stocks Are Ignoring Medicare\u2019s 10 Drug List","Summary":""},{"Date":"Aug. 29, 2023 at 3:22 p.m. ET","Headline":"Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations","Summary":""},{"Date":"Aug. 28, 2023 at 3:00 a.m. ET","Headline":"Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For","Summary":""},{"Date":"Aug. 30, 2023 at 3:56 p.m. ET","Headline":"Medicare\u2019s Plan to Negotiate Drug Discounts Won\u2019t Hit Pharma Hard, Analysts say","Summary":""},{"Date":"Aug. 30, 2023 at 6:46 a.m. ET","Headline":"Crypto Scores Big Win Over the SEC. Why the Battle\u2019s Far From Over.","Summary":""}]